Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Wells Fargo Adjusts Medtronic's Price Target to $137 From $144, Reiterates Overweight Rating

11/24/2021 | 11:29am EST


© MT Newswires 2021
All news about MEDTRONIC PLC
01/21Health Care Stocks Retreat This Afternoon
MT
01/21Health Care Stocks Drifting Lower in Friday Trade
MT
01/21SVB Leerink Adjusts Medtronic Price Target to $115 From $138, Maintains Market Perform ..
MT
01/21Medtronic Issues Recall for HawkOne Atherectomy System
MT
01/19Citigroup Adjusts Medtronic's Price Target to $129 from $130, Keeps Buy Rating
MT
01/18Goldman Sachs Adjusts Medtronic Price Target to $115 From $129, Maintains Neutral Ratin..
MT
01/14Medtronic Says Data From DTM Spinal Cord Stimulation Endurance Therapy Study Shows Mean..
MT
01/14Medtronic announces results showing meaningful pain relief using DTM™ Spinal Cord..
AQ
01/14Medtronic plc Announces Three-Month Results from an On-Label, Prospective, Multi-Center..
CI
01/12Medtronic announces schedule for presentations at the 2022 North American Neuromodulati..
AQ
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 319 M - -
Net income 2022 5 521 M - -
Net Debt 2022 21 686 M - -
P/E ratio 2022 26,0x
Yield 2022 2,37%
Capitalization 142 B 142 B -
EV / Sales 2022 5,06x
EV / Sales 2023 4,72x
Nbr of Employees 90 000
Free-Float 99,8%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 105,60 $
Average target price 129,84 $
Spread / Average Target 23,0%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz President-Medtronic Neuromodulation & SVP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC2.57%141 985
ABBOTT LABORATORIES-10.59%215 794
BECTON, DICKINSON AND COMPANY5.23%75 431
HOYA CORPORATION-11.34%49 186
BAXTER INTERNATIONAL INC.0.51%43 200
DEXCOM, INC.-21.39%40 911